Position in ARWR
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$40,755
New position
Shares Held
500
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#410
of 490 holders
Holding Since
Jun 2026
1 quarter on record
Position in Biotechnology
Healthcare · as of Jun 30, 2026Archer Investment Corp holds $770,235 across 19 Biotechnology names. ARWR ranks #7 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KRYS |
Krystal Biotech, Inc.
|
830 | $308,486 | |
| 2 | GALT |
Galectin Therapeutics Inc
|
17,401 | $80,740 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
1,000 | $78,270 | |
| 4 | PVLA |
Palvella Therapeutics, Inc.
|
449 | $68,616 | |
| 5 | IBRX |
ImmunityBio, Inc.
|
5,872 | $51,409 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
600 | $47,574 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
This page
|
500 | $40,755 | |
| 8 | MRNA |
Moderna, Inc.
|
520 | $36,415 |
All Filings in ARWR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,755 | 500 | Shares | Sole | 2026-08-03 | |
| No filing history on record for this holder in this stock. | ||||||